|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C12N 15/13 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 2374818 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11171039.8 |
| Date of filing the European patent application | 2007-06-01 | |
| (97) | Date of publication of the European application | 2011-10-12 |
| (45) | Date of publication and mention of the grant of the patent | 2012-12-19 |
| (46) | Date of publication of the claims translation | 2013-02-25 |
| (30) | Number | Date | Country code |
| 810664 P | 2006-06-02 | US | |
| 843232 P | 2006-09-08 | US |
| (72) |
Stevens, Sean, US
Huang, Tammy T, US
Martin, Joel H, US
Fairhurst, Jeanette L, US
Rafique, Ashique, US
Smith, Eric, US
Pobursky, Kevin J, US
Papadopoulos, Nicholas J, US
Fandl, James P, US
Chen, Gang, US
Karow, Margaret, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Didelio giminingumo antikūnai prieš žmogaus IL-6 receptorių |
| High affinity antibodies to human IL-6 receptor |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 19 | 347.00 EUR |
| 2026-06-01 |